InvestSMART

EBR Systems Inc (ASX: EBR) - Announcements

Current share price for EBR : $0.155 0.015 (8.82%)+

ASX company news and announcements for EBR Systems Inc (EBR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EBR Systems Inc (EBR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EBR Systems Inc (EBR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EBR Systems Inc (EBR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$131 Notification of cessation of securities - EBR 15 Dec 2025 10:22AM $0.880 $0.155 fallen by 82.39%
$131 First implant in the Totally Leadless CRT (TLC-AU) Study 12 Dec 2025 8:52AM $0.905 $0.155 fallen by 82.87%
$131 Notification regarding unquoted securities - EBR 11 Dec 2025 4:45PM $0.905 $0.155 fallen by 82.87%
$131 Intellectual Property Portfolio Updates 11 Dec 2025 9:14AM $0.885 $0.155 fallen by 82.49%
$131 Application for quotation of securities - EBR 10 Dec 2025 11:15AM $0.940 $0.155 fallen by 83.51%
$131 The Piper Sandler 37th Annual Healthcare Conference Slides 1 Dec 2025 1:43PM $1.040 $0.155 fallen by 85.10%
$131 EBR to Present at the Bell Potter Healthcare Conference 2025 18 Nov 2025 8:27AM $1.110 $0.155 fallen by 86.04%
$131 Notification of cessation of securities - EBR 13 Nov 2025 10:45AM $1.180 $0.155 fallen by 86.86%
$131 Q3 2025 Form 10-Q submission and Quarterly Activity Report 13 Nov 2025 8:28AM $1.190 $0.155 fallen by 86.97%
$131 Notification regarding unquoted securities - EBR 11 Nov 2025 9:02AM $1.185 $0.155 fallen by 86.92%
$131 Application for quotation of securities - EBR 7 Nov 2025 2:57PM $1.200 $0.155 fallen by 87.08%
$131 First Two Patients Enrolled in WiSE-UP Post-Approval Study 6 Nov 2025 9:06AM $1.170 $0.155 fallen by 86.75%
$131 EBR Systems to Participate at the Canaccord Genuity Forum 6 Nov 2025 8:52AM $1.170 $0.155 fallen by 86.75%
$131 EBR Executives to Speak at Upcoming Investor Conferences 20 Oct 2025 9:06AM $1.345 $0.155 fallen by 88.48%
$131 Notification of cessation of securities - EBR 15 Oct 2025 9:38AM $1.270 $0.155 fallen by 87.80%
$131 Notification regarding unquoted securities - EBR 14 Oct 2025 11:07AM $1.305 $0.155 fallen by 88.12%
$131 Application for quotation of securities - EBR 10 Oct 2025 2:52PM $1.293 $0.155 fallen by 88.01%
$131 Drug & Device Conference Presentation 9 Oct 2025 9:06AM $1.280 $0.155 fallen by 87.89%
$131 Investor Roadshow 9 Oct 2025 9:01AM $1.280 $0.155 fallen by 87.89%
$131 HealthInvest 2025 Investor Presentation 22 Sep 2025 10:10AM $1.220 $0.155 fallen by 87.30%
$131 Final CMS Approval Received for TPT Reimbursement 22 Sep 2025 10:06AM $1.220 $0.155 fallen by 87.30%
$131 EBR Passes Tenth US Commercial Implant Milestone 17 Sep 2025 9:11AM $1.170 $0.155 fallen by 86.75%
$131 Notification of cessation of securities - EBR 15 Sep 2025 11:03AM $1.170 $0.155 fallen by 86.75%
$131 Notification regarding unquoted securities - EBR 11 Sep 2025 3:21PM $1.110 $0.155 fallen by 86.04%
$131 Application for quotation of securities - EBR 10 Sep 2025 10:22AM $1.120 $0.155 fallen by 86.16%

101 - 125 of 517 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.